OA
IPXL

OFI Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

OFI Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$279K Buy
7,934
+351
+5% +$15.8K 0.02% 1031
2015
Q2 		$348K Buy
7,583
+426
+6% +$20.2K 0.02% 967
2015
Q1 		$335K Sell
7,157
-1,486
-17% -$59.1K 0.02% 972
2014
Q4 		$274K Sell
8,643
-1,378
-14% -$40.3K 0.02% 1040
2014
Q3 		$238K Buy
10,021
+2,317
+30% +$59.4K 0.02% 1048
2014
Q2 		$231K Sell
7,704
-290
-4% -$7.82K 0.02% 1079
2014
Q1 		$211K Sell
7,994
-1,608
-17% -$40.2K 0.02% 1079
2013
Q4 		$241K Buy
9,602
+447
+5% +$9.97K 0.02% 985
2013
Q3 		$187K Buy
9,155
+525
+6% +$10.8K 0.02% 1005
2013
Q2 		$172K Buy
+8,630
New +$153K 0.02% 968

Other funds holding IPXL

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

OFI Advisors's IPXL Position: Q3 2015 in Review

OFI Advisors increased its Impax Laboratories, Inc. (IPXL) stake by 4.6% in Q3 2015, buying an estimated $15.8K and bringing the position to 7,934 shares worth $279K. The position accounts for 0.02% of the portfolio, ranked #1031.

OFI Advisors first reported a position in IPXL in Q2 2013 and has held it in 10 quarters since. The position peaked at $348K in Q2 2015. 195 funds tracked by Wall St. Rank hold IPXL as of Q3 2015.

  • OFI Advisors held 7,934 shares of Impax Laboratories, Inc. worth $279K as of Q3 2015.
  • OFI Advisors bought 351 Impax Laboratories, Inc. shares in Q3 2015, an estimated $15.8K.
  • Impax Laboratories, Inc. made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #1031 holding.
  • OFI Advisors first reported a position in Impax Laboratories, Inc. in Q2 2013 and has held it in 10 quarters since.
  • OFI Advisors's Impax Laboratories, Inc. position peaked at $348K in Q2 2015.
  • 195 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.